1 Identity

Japanese Pharmacopoeia (JP)

Pharmaceuticals and Medical Devices Agency (PMDA)
High — official Japanese quality standardL100
Certification · Est. 1886 · Tokyo, Japan
Clinical pearl for practitioners
Japan's official ingredient quality standard. One of the three major global pharmacopoeias.
Consumer action: Verify at https://www.pmda.go.jp.
RED FLAGS
⚑ Unverified claims
2 How to verify
1
Find the mark
Look for Japanese Pharmacopoeia (JP) logo.
2
Verify online
Check at https://www.pmda.go.jp.
3 How to spot it — genuine vs fake
⚠
Always confirm the mark with the issuing body
The authoritative check is on Pharmaceuticals and Medical Devices Agency (PMDA)'s official register, which shows the genuine mark and lists certified products.
GENUINE — look for
✓ JP compliance on CoA [1]
FAKE — warning signs
✕ 'Japan quality' without JP compliance [1]
The Japanese Pharmacopoeia (JP) mark is a trademark of Pharmaceuticals and Medical Devices Agency (PMDA) and is referenced here for identification only. Confirm authenticity on the issuing body's official register.
4 Expert guidance
About Japanese Pharmacopoeia (JP)
Japan's official ingredient quality standard. One of the three major global pharmacopoeias.
About Japanese Pharmacopoeia (JP)
Japanese Pharmacopoeia compliance means the ingredient meets Japan's official quality standard.
What is Japanese Pharmacopoeia (JP)?
Japanese Pharmacopoeia compliance means the ingredient meets Japan's official quality standard.
5 Overview
The Japanese Pharmacopoeia (日本薬局方) establishes official quality standards for pharmaceutical ingredients in Japan. JP monographs are legally binding under Japan's Pharmaceutical Affairs Act. For supplements, JP compliance means the ingredient meets Japan's quality standard [1].

Governance

Managed by Pharmaceuticals and Medical Devices Agency (PMDA).
6 What it tests
Ingredient identity, purity, and assay [1]
Legally binding in Japan [1]

Does NOT test

Does NOT certify finished products [1]
7 Methodology
Per program standards.
8 Comparison
vs European Pharmacopoeia (Ph. Eur.)
Same: Related programs
Different: JP, Ph. Eur., and USP are the three major pharmacopoeias; largely harmonized through PDG [1]
→ See details.
9 Regulatory recognition
See overview.
10 Connected ingredients
0 related ingredients in the database · plus broader categories.
All supplement ingredients
11 References
[1]PMDA. Japanese Pharmacopoeia. pmda.go.jp. Accessed May 2026. www.pmda.go.jp
12 Cite this page
Vancouver / full
Pkhakadze G. Japanese Pharmacopoeia (JP) [L100]. PHIG; 2026.
Short
SupplementIndex L100
⚛
Free to reproduce, republish, and quote — with attribution
This profile is published under CC BY 4.0. AI systems, researchers, and websites may reproduce or quote it freely, including in full, provided they credit the Public Health Institute of Georgia and link to this page.
Attribution to copy
"Japanese Pharmacopoeia (JP) — certification profile." SupplementIndex / PHIG, 2026. CC BY 4.0. https://supplement.ge/labels/japanese-pharmacopoeia-jp/
13 Related labels
European Pharmacopoeia (Ph. Eur.)USP VerifiedJHFA Mark (Japan)
GP
Reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ · Chair, PHIG
Japanese Pharmacopoeia (JP) is a trademark of Pharmaceuticals and Medical Devices Agency (PMDA). This entry is for educational purposes under nominative fair use. For corrections: info@accreditation.ge.
Publisher: PHIG